Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Current Cancer Drug Targets|November 11, 2010
Immunotherapy for myeloproliferative neoplasms (MPN)Susanne Hofmann, Anna Babiak, Jochen GreinerLeukemia Research|April 3, 2010
Immunogenic antigens as therapeutic targets against myeloid leukaemic cellsSusanne Hofmann, Jochen GreinerTransfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 16, 2011
Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion MedicineSusanne Hofmann, Jochen GreinerClinical & Developmental Immunology|May 22, 2012
Immunogenic targets for specific immunotherapy in multiple myelomaLu Zhang, Marlies Götz, Susanne Hofmann, et al.Oncology Reports|October 25, 2013
Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapyAnna Babiak, Max Steinhauser, Marlies Götz, et al.Journal of Clinical Medicine|December 28, 2019
Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML PatientsJochen Greiner, Marlies Götz, Donald Bunjes, et al.Leukemia & Lymphoma|October 30, 2012
Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemiaVanessa Schneider, Stephanie Egenrieder, Marlies Götz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17)Lars Bullinger, Richard F Schlenk, Marlies Götz, et al.International Journal of Cancer|July 15, 2018
Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical respondersSusanne Hofmann, Michael Schmitt, Marlies Götz, et al.Cancer Immunology, Immunotherapy : CII|February 6, 2020
Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibitionJochen Greiner, Marlies Götz, Susanne Hofmann, et al.Pageof 9